Intraductal Papillary Mucinous Neoplasm of Pancreas

被引:94
|
作者
Machado, Norman Oneil [1 ]
al Qadhi, Hani [1 ]
al Wahibi, Khalifa [1 ]
机构
[1] Sultan Qaboos Univ Hosp, Dept Surg, POB 38, Muscat 123, Oman
关键词
Carcinoma of pancreas; Cystic tumors of pancreas; Intraductal papillary mucinous neoplasm (IPMN); Magnetic resonance cholangiopancreatography (MRCP);
D O I
10.4103/1947-2714.157477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are neoplasms that are characterized by ductal dilation, intraductal papillary growth, and thick mucus secretion. This relatively recently defined pathology is evolving in terms of its etiopathogenesis, clinical features, diagnosis, management, and treatment guidelines. A PubMed database search was performed. All the relevant abstracts in English language were reviewed and the articles in which cases of IPMN could be identified were further scrutinized. Information of IPMN was derived, and duplication of information in several articles and those with areas of persisting uncertainties were excluded. The recent consensus guidelines were examined. The reported incidence of malignancy varies from 57% to 92% in the main duct- IPMN (MD-IPMN) and from 6% to 46% in the branch duct-IPMN (BD-IPMN). The features of high-risk malignant lesions that raise concern include obstructive jaundice in a patient with a cystic lesion in the pancreatic head, the findings on radiological imaging of a mass lesion of >30 mm, enhanced solid component, and the main pancreatic duct (MPD) of size >= 10 mm; while duct size 5-9 mm and cyst size <3 mm are considered as "worrisome features." Magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) are primary investigations in diagnosing and following up on these patients. The role of pancreatoscopy and the analysis of aspirated cystic fluid for cytology and DNA analysis is still to be established. In general, resection is recommended for most MD-IPMN, mixed variant, and symptomatic BD-IPMN. The 5-year survival of patients after surgical resection for noninvasive IPMN is reported to be at 77-100%, while for those with invasive carcinoma, it is significantly lower at 27-60%. The follow-up of these patients could vary from 6 months to 1 year and would depend on the risk stratification for invasive malignancy and the pathology of the resected specimen. The understanding of IPMN has evolved over the years. The recent guidelines have played a role in this regard.
引用
收藏
页码:160 / 175
页数:16
相关论文
共 50 条
  • [41] Intraductal papillary mucinous neoplasm in an annular pancreas: a case report
    Kobayashi, Shinichiro
    Kamohara, Yukio
    Nagata, Yasuhiro
    Ito, Masahiro
    Fujioka, Hikaru
    SURGICAL CASE REPORTS, 2015, 1
  • [42] MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas
    Lubezky, Nir
    Loewenstein, Shelly
    Ben-Haim, Menahem
    Brazowski, Eli
    Marmor, Sylvia
    Pasnmnik-Chor, Metsada
    Oron-Karni, Varda
    Rechavi, Gideon
    Klausner, Joseph M.
    Lahat, Guy
    SURGERY, 2013, 153 (05) : 663 - 672
  • [43] Intraductal Papillary Mucinous Neoplasm in Pancreas Divisum: A Case Series
    Shah, Rushikesh
    Mekaroonkamol, Parit
    Raphael, Kara L.
    Cai, Qiang
    Keilin, Steven A.
    Willingham, Field F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S758 - S759
  • [44] Pseudomyxoma peritonei accompanied by intraductal papillary mucinous neoplasm of the pancreas
    Mizuta, Y
    Akazawa, Y
    Shiozawa, K
    Ohara, H
    Ohba, K
    Ohnita, K
    Isomoto, H
    Takeshima, F
    Omagari, K
    Tanaka, K
    Yasutake, T
    Nakagoe, T
    Shirono, K
    Kohno, S
    PANCREATOLOGY, 2005, 5 (4-5) : 470 - 474
  • [45] Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas
    Schnelldorfer, Thomas
    Sarr, Michael G.
    Nagorney, David M.
    Zhang, Lizhi
    Smyrk, Thomas C.
    Qin, Rui
    Chari, Suresh T.
    Farnell, Michael B.
    ARCHIVES OF SURGERY, 2008, 143 (07) : 639 - 646
  • [46] Intraductal papillary mucinous neoplasm of the pancreas: Cytologic findings in subtypes
    Shimizu, M.
    Ban, S.
    Maniwa, J.
    Kawashima, K.
    Shimizu, Y.
    ACTA CYTOLOGICA, 2007, 51 (02) : 314 - 315
  • [47] Concomitant intraductal papillary mucinous neoplasm and neuroendocrine tumor of the pancreas
    Ishida, Mitsuaki
    Shiomi, Hisanori
    Naka, Shigeyuki
    Tani, Tohru
    Okabe, Hidetoshi
    ONCOLOGY LETTERS, 2013, 5 (01) : 63 - 67
  • [48] Expression of Matrix Metalloproteinases in Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Akashi, Masanori
    Hisaka, Toru
    Sakai, Hisamune
    Ishikawa, Hiroto
    Kawahara, Ryuichi
    Goto, Yuichi
    Nomura, Yoriko
    Yasunaga, Masafumi
    Fujita, Fumihiko
    Tanigawa, Masahiko
    Naito, Yoshiki
    Akiba, Jun
    Yano, Hirohisa
    Tanaka, Hiroyuki
    Akagi, Yoshito
    Okuda, Koji
    ANTICANCER RESEARCH, 2019, 39 (08) : 4485 - 4490
  • [49] Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
    Michael B. Farnell
    Journal of Gastrointestinal Surgery, 2008, 12 : 414 - 416
  • [50] Reproducibility of the Morphologic Subtypes of Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Kwak, Heewon
    Liu, Xiuli
    Allende, Daniela
    Pai, Rish
    Hart, John
    Xiao, Shu-Yuan
    MODERN PATHOLOGY, 2015, 28 : 444A - 445A